Trends in neonatal morbidity and mortality for very low birthweight infants

Avroy A. Fanaroff, Barbara J. Stoll, Linda L. Wright, Waldemar A. Carlo, Richard A. Ehrenkranz, Ann R. Stark, Charles R Bauer, Edward F. Donovan, Sheldon B. Korones, Abbot R. Laptook, James A. Lemons, William Oh, Lu Ann Papile, Seetha Shankaran, David K. Stevenson, Jon E. Tyson, W. Kenneth Poole

Research output: Contribution to journalArticle

747 Citations (Scopus)

Abstract

Objective: To document the mortality and morbidity of infants weighing 501-1500 g at birth according to gestational age, birthweight, and sex. Study design: Prospective collection of perinatal events and neonatal course to 120 days of life, discharge, or death from January 1990 through December 2002 for infants born at 16 participating centers of the National Institute of Child Health & Human Development Neonatal Research Network. Results: Compared with 1995-1996, for 1997-2002 the survival of infants with birthweight of 501-1500 g increased by 1 percentage point (from 84% to 85%). Survival without major neonatal morbidity remained static, at 70%; this includes bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Survival increased for multiple births (26%, up from 22%), antenatal corticosteroid use (79%, up from 71%), and maternal antibiotics (70%, up from 62%) (P < .05). From 1997 to 2002, birthweight-specific survival was 55% for infants weighing 501-750 g, 88% for 751-1000 g, 94% for 1001-1250 g, and 96% for 1251-1500 g. More females survived. The incidence of NEC (7%), severe IVH (12%), and late-onset septicemia (22%) remained essentially unchanged, but BPD decreased slightly, from 23% to 22%. The use of postnatal corticosteroids declined from 20% in 1997-2000 to 12% in 2001-2002. Growth failure (weight <10th percentile) at 36 weeks' postmenstrual age decreased from 97% in 1995-1996 to 91% in 1997-2002. Conclusion: There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002. We speculate that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.

Original languageEnglish
JournalAmerican Journal of Obstetrics and Gynecology
Volume196
Issue number2
DOIs
StatePublished - Feb 1 2007

Fingerprint

Infant Mortality
Morbidity
Survival
Bronchopulmonary Dysplasia
Necrotizing Enterocolitis
Adrenal Cortex Hormones
Hemorrhage
Multiple Birth Offspring
National Institutes of Health (U.S.)
Human Development
Practice Guidelines
Gestational Age
Sepsis
Mothers
Parturition
Prospective Studies
Anti-Bacterial Agents
Weights and Measures
Incidence
Growth

Keywords

  • limits of viability
  • morbidity
  • mortality
  • NICHD Neonatal Research Network
  • prematurity
  • preterm delivery
  • very low birthweight

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Fanaroff, A. A., Stoll, B. J., Wright, L. L., Carlo, W. A., Ehrenkranz, R. A., Stark, A. R., ... Poole, W. K. (2007). Trends in neonatal morbidity and mortality for very low birthweight infants. American Journal of Obstetrics and Gynecology, 196(2). https://doi.org/10.1016/j.ajog.2006.09.014

Trends in neonatal morbidity and mortality for very low birthweight infants. / Fanaroff, Avroy A.; Stoll, Barbara J.; Wright, Linda L.; Carlo, Waldemar A.; Ehrenkranz, Richard A.; Stark, Ann R.; Bauer, Charles R; Donovan, Edward F.; Korones, Sheldon B.; Laptook, Abbot R.; Lemons, James A.; Oh, William; Papile, Lu Ann; Shankaran, Seetha; Stevenson, David K.; Tyson, Jon E.; Poole, W. Kenneth.

In: American Journal of Obstetrics and Gynecology, Vol. 196, No. 2, 01.02.2007.

Research output: Contribution to journalArticle

Fanaroff, AA, Stoll, BJ, Wright, LL, Carlo, WA, Ehrenkranz, RA, Stark, AR, Bauer, CR, Donovan, EF, Korones, SB, Laptook, AR, Lemons, JA, Oh, W, Papile, LA, Shankaran, S, Stevenson, DK, Tyson, JE & Poole, WK 2007, 'Trends in neonatal morbidity and mortality for very low birthweight infants', American Journal of Obstetrics and Gynecology, vol. 196, no. 2. https://doi.org/10.1016/j.ajog.2006.09.014
Fanaroff, Avroy A. ; Stoll, Barbara J. ; Wright, Linda L. ; Carlo, Waldemar A. ; Ehrenkranz, Richard A. ; Stark, Ann R. ; Bauer, Charles R ; Donovan, Edward F. ; Korones, Sheldon B. ; Laptook, Abbot R. ; Lemons, James A. ; Oh, William ; Papile, Lu Ann ; Shankaran, Seetha ; Stevenson, David K. ; Tyson, Jon E. ; Poole, W. Kenneth. / Trends in neonatal morbidity and mortality for very low birthweight infants. In: American Journal of Obstetrics and Gynecology. 2007 ; Vol. 196, No. 2.
@article{1fdf2d161eaa41a2af51c3b650eae758,
title = "Trends in neonatal morbidity and mortality for very low birthweight infants",
abstract = "Objective: To document the mortality and morbidity of infants weighing 501-1500 g at birth according to gestational age, birthweight, and sex. Study design: Prospective collection of perinatal events and neonatal course to 120 days of life, discharge, or death from January 1990 through December 2002 for infants born at 16 participating centers of the National Institute of Child Health & Human Development Neonatal Research Network. Results: Compared with 1995-1996, for 1997-2002 the survival of infants with birthweight of 501-1500 g increased by 1 percentage point (from 84{\%} to 85{\%}). Survival without major neonatal morbidity remained static, at 70{\%}; this includes bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Survival increased for multiple births (26{\%}, up from 22{\%}), antenatal corticosteroid use (79{\%}, up from 71{\%}), and maternal antibiotics (70{\%}, up from 62{\%}) (P < .05). From 1997 to 2002, birthweight-specific survival was 55{\%} for infants weighing 501-750 g, 88{\%} for 751-1000 g, 94{\%} for 1001-1250 g, and 96{\%} for 1251-1500 g. More females survived. The incidence of NEC (7{\%}), severe IVH (12{\%}), and late-onset septicemia (22{\%}) remained essentially unchanged, but BPD decreased slightly, from 23{\%} to 22{\%}. The use of postnatal corticosteroids declined from 20{\%} in 1997-2000 to 12{\%} in 2001-2002. Growth failure (weight <10th percentile) at 36 weeks' postmenstrual age decreased from 97{\%} in 1995-1996 to 91{\%} in 1997-2002. Conclusion: There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002. We speculate that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.",
keywords = "limits of viability, morbidity, mortality, NICHD Neonatal Research Network, prematurity, preterm delivery, very low birthweight",
author = "Fanaroff, {Avroy A.} and Stoll, {Barbara J.} and Wright, {Linda L.} and Carlo, {Waldemar A.} and Ehrenkranz, {Richard A.} and Stark, {Ann R.} and Bauer, {Charles R} and Donovan, {Edward F.} and Korones, {Sheldon B.} and Laptook, {Abbot R.} and Lemons, {James A.} and William Oh and Papile, {Lu Ann} and Seetha Shankaran and Stevenson, {David K.} and Tyson, {Jon E.} and Poole, {W. Kenneth}",
year = "2007",
month = "2",
day = "1",
doi = "10.1016/j.ajog.2006.09.014",
language = "English",
volume = "196",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Trends in neonatal morbidity and mortality for very low birthweight infants

AU - Fanaroff, Avroy A.

AU - Stoll, Barbara J.

AU - Wright, Linda L.

AU - Carlo, Waldemar A.

AU - Ehrenkranz, Richard A.

AU - Stark, Ann R.

AU - Bauer, Charles R

AU - Donovan, Edward F.

AU - Korones, Sheldon B.

AU - Laptook, Abbot R.

AU - Lemons, James A.

AU - Oh, William

AU - Papile, Lu Ann

AU - Shankaran, Seetha

AU - Stevenson, David K.

AU - Tyson, Jon E.

AU - Poole, W. Kenneth

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Objective: To document the mortality and morbidity of infants weighing 501-1500 g at birth according to gestational age, birthweight, and sex. Study design: Prospective collection of perinatal events and neonatal course to 120 days of life, discharge, or death from January 1990 through December 2002 for infants born at 16 participating centers of the National Institute of Child Health & Human Development Neonatal Research Network. Results: Compared with 1995-1996, for 1997-2002 the survival of infants with birthweight of 501-1500 g increased by 1 percentage point (from 84% to 85%). Survival without major neonatal morbidity remained static, at 70%; this includes bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Survival increased for multiple births (26%, up from 22%), antenatal corticosteroid use (79%, up from 71%), and maternal antibiotics (70%, up from 62%) (P < .05). From 1997 to 2002, birthweight-specific survival was 55% for infants weighing 501-750 g, 88% for 751-1000 g, 94% for 1001-1250 g, and 96% for 1251-1500 g. More females survived. The incidence of NEC (7%), severe IVH (12%), and late-onset septicemia (22%) remained essentially unchanged, but BPD decreased slightly, from 23% to 22%. The use of postnatal corticosteroids declined from 20% in 1997-2000 to 12% in 2001-2002. Growth failure (weight <10th percentile) at 36 weeks' postmenstrual age decreased from 97% in 1995-1996 to 91% in 1997-2002. Conclusion: There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002. We speculate that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.

AB - Objective: To document the mortality and morbidity of infants weighing 501-1500 g at birth according to gestational age, birthweight, and sex. Study design: Prospective collection of perinatal events and neonatal course to 120 days of life, discharge, or death from January 1990 through December 2002 for infants born at 16 participating centers of the National Institute of Child Health & Human Development Neonatal Research Network. Results: Compared with 1995-1996, for 1997-2002 the survival of infants with birthweight of 501-1500 g increased by 1 percentage point (from 84% to 85%). Survival without major neonatal morbidity remained static, at 70%; this includes bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Survival increased for multiple births (26%, up from 22%), antenatal corticosteroid use (79%, up from 71%), and maternal antibiotics (70%, up from 62%) (P < .05). From 1997 to 2002, birthweight-specific survival was 55% for infants weighing 501-750 g, 88% for 751-1000 g, 94% for 1001-1250 g, and 96% for 1251-1500 g. More females survived. The incidence of NEC (7%), severe IVH (12%), and late-onset septicemia (22%) remained essentially unchanged, but BPD decreased slightly, from 23% to 22%. The use of postnatal corticosteroids declined from 20% in 1997-2000 to 12% in 2001-2002. Growth failure (weight <10th percentile) at 36 weeks' postmenstrual age decreased from 97% in 1995-1996 to 91% in 1997-2002. Conclusion: There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002. We speculate that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.

KW - limits of viability

KW - morbidity

KW - mortality

KW - NICHD Neonatal Research Network

KW - prematurity

KW - preterm delivery

KW - very low birthweight

UR - http://www.scopus.com/inward/record.url?scp=33846894800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846894800&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2006.09.014

DO - 10.1016/j.ajog.2006.09.014

M3 - Article

C2 - 17306659

AN - SCOPUS:33846894800

VL - 196

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -